Literature DB >> 15448751

Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of p53 and bcl-2.

Zahra Amirghofran1, Ahmad Monabati, Abdolaziz Khezri, Zahra Malek-Hosseini.   

Abstract

Transitional cell carcinoma of bladder (TCC) is a relatively common cancer among men. Tumor progression is associated with expression or modulation of several gene products that control apoptosis and proliferation. Apoptosis is a negative growth regulatory mechanism in tumors. The aim of this study is to examine apoptosis and related regulatory molecular markers in a group of patients with TCC. Paraffinembedded tissues from 49 patients with TCC were examined for the expression of bcl-2, p53 and Ki-67 by immunohistochemistry. Apoptosis was detected by TUNEL method. Correlation between apoptotic index (AI), proliferation index (PI) and bcl-2 and p53 expression with each other and with pathological grade was determined. Apoptosis was observed in 28.1% of TCC cases. The mean AI of all cases was 13.7+/-24. No correlation was found between apoptosis and differentiation status of carcinoma. Bcl-2 expression was weakly detected in only one sample. P53 expression was detected in 26 of cases with mean staining index of 102+/-96. A significant correlation between p53 and Ki-67 staining indices was observed (r=0.521, p=0.001). Both p53 and Ki-67 expression showed a good association with the pathological grade (p=0.0001 and p=0.004, respectively). None of the markers showed significant correlation with AI and no correlation was found between the ratio of AI to PI and other parameters either. In conclusion, the frequency of apoptosis in TCC of bladder appears not to be associated with tumor grade, and with bcl-2, p53 and Ki-67 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448751     DOI: 10.1007/bf03033744

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

1.  The expression of oncoproteins in transitional cell carcinoma: its correlation with pathological behavior, cell cycle and drug resistance.

Authors:  Dah-Shyong Yu; Sun-Yran Chang
Journal:  Urol Int       Date:  2002       Impact factor: 2.089

Review 2.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

Review 3.  Regulation of apoptosis by Bcl-2 family proteins.

Authors:  Alexandrina Burlacu
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

4.  Apoptotic cell death and Smad4 expression in transitional cell carcinoma of the renal pelvis and ureter.

Authors:  C Kong; X Zhang; I Takenaka
Journal:  Int J Urol       Date:  2001-07       Impact factor: 3.369

5.  p53 expression predicts progression and poor survival in T1 bladder tumours.

Authors:  J Llopis; A Alcaraz; M J Ribal; M Solé; P J Ventura; M A Barranco; A Rodriguez; J M Corral; P Carretero
Journal:  Eur Urol       Date:  2000-06       Impact factor: 20.096

Review 6.  Multiple roles of the tumor suppressor p53.

Authors:  Jill Bargonetti; James J Manfredi
Journal:  Curr Opin Oncol       Date:  2002-01       Impact factor: 3.645

7.  Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma.

Authors:  Andrés Rodríguez-Alonso; Salvador Pita-Fernández; Joaquín González-Carreró; José Luis Nogueira-March
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

8.  Expression of bcl-2 and bcl-X in bladder cancer.

Authors:  E J Kirsh; D A Baunoch; W M Stadler
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

Review 9.  Protein p53--structure, function, and possible therapeutic implications.

Authors:  Tanja Batinac; Franjo Gruber; Jasna Lipozencić; Gordana Zamolo-Koncar; Adalbert Stasić; Ines Brajac
Journal:  Acta Dermatovenerol Croat       Date:  2003-12       Impact factor: 1.256

Review 10.  Principles of tumor suppression.

Authors:  Charles J Sherr
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.